Tolerability
In clinical trials of subjects with childhood acute ITP, adults and children with chronic
ITP, and adults and children with ITP secondary to HIV, only 7% of infusions were
associated with at least one adverse event related to WinRho SDF.
| WinRho® SDF Tolerability* | |
Most Common Adverse Events |
Frequency † |
Headache |
2% |
Chills |
<2% |
Fever |
1% |
† n=848 infusions
*Studies were performed using WinRho/WinRho SD
Please see Important Safety Information and Prescribing Information.
